Keenan A - Search Results

1

C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.

Zhang Y, Meyer NC, Fervenza FC, Lau W, Keenan A, Cara-Fuentes G, Shao D, Akber A, Fremeaux-Bacchi V, Sethi S, Nester CM, Smith RJH. Zhang Y, et al. Among authors: keenan a. Am J Kidney Dis. 2017 Dec;70(6):834-843. doi: 10.1053/j.ajkd.2017.07.004. Epub 2017 Aug 24. Am J Kidney Dis. 2017. PMID: 28838767 Free PMC article.

2

C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice.

Zhang Y, Keenan A, Dai DF, May KS, Anderson EE, Lindorfer MA, Henrich JB, Pitcher GR, Taylor RP, Smith RJ. Zhang Y, et al. Among authors: keenan a. JCI Insight. 2020 May 7;5(9):e135758. doi: 10.1172/jci.insight.135758. JCI Insight. 2020. PMID: 32376801 Free PMC article.

3

Brain volume loss in relapsing multiple sclerosis: indirect treatment comparisons of available disease-modifying therapies.

Zivadinov R, Keenan AJ, Le HH, Ait-Tihyaty M, Gandhi K, Zierhut ML, Salvo-Halloran EM, Ramirez AO, Vuong V, Singh S, Hutton B. Zivadinov R, et al. Among authors: keenan aj. BMC Neurol. 2024 Oct 8;24(1):378. doi: 10.1186/s12883-024-03888-6. BMC Neurol. 2024. PMID: 39379875 Free PMC article.

4

Clinicians' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment.

Keenan A, Whichello C, Le HH, Kern DM, Fernandez GS, Turner V, Das A, Quaife M, Ross AP. Keenan A, et al. Pharmacoecon Open. 2024 Nov;8(6):857-867. doi: 10.1007/s41669-024-00510-w. Epub 2024 Aug 28. Pharmacoecon Open. 2024. PMID: 39196477 Free PMC article.

5

Physician perspectives of the community paramedicine at clinic (CP@clinic) and my care plan app (myCP app) for older adults.

Sadri P, Keenan A, Angeles R, Marzanek F, Pirrie M, Agarwal G. Sadri P, et al. Among authors: keenan a. BMC Prim Care. 2024 May 25;25(1):187. doi: 10.1186/s12875-024-02436-y. BMC Prim Care. 2024. PMID: 38796442 Free PMC article.

6

Patients' Preferences for Sphingosine-1-Phosphate Receptor Modulators in Multiple Sclerosis Based on Clinical Management Considerations: A Choice Experiment.

Keenan A, Whichello C, Le HH, Kern DM, Fernandez GS, Turner V, Das A, Quaife M, Ross AP. Keenan A, et al. Patient. 2024 Nov;17(6):685-696. doi: 10.1007/s40271-024-00699-2. Epub 2024 May 15. Patient. 2024. PMID: 38748388

7

Longer Menstrual Cycle and Infertility Evaluation.

Keenan A. Keenan A. Am Fam Physician. 2024 Apr;109(4):296-298. Am Fam Physician. 2024. PMID: 38648821 No abstract available.

8

Comparison of low-dose maximal-intent versus controlled-tempo resistance training on quality-of-life, functional capacity, and strength in untrained healthy adults: a comparative effectiveness study.

Pearson LT, Fox KT, Keenan A, Behm DG, Stuart S, Goodall S, Barry G. Pearson LT, et al. Among authors: keenan a. BMC Sports Sci Med Rehabil. 2024 Mar 23;16(1):72. doi: 10.1186/s13102-024-00847-z. BMC Sports Sci Med Rehabil. 2024. PMID: 38521946 Free PMC article.

9

Pathophysiology, Assessment, and Management of Post-Stroke Cognitive Impairment, Depression, and Fatigue.

Jaywant A, Keenan A. Jaywant A, et al. Among authors: keenan a. Phys Med Rehabil Clin N Am. 2024 May;35(2):463-478. doi: 10.1016/j.pmr.2023.06.028. Epub 2023 Aug 12. Phys Med Rehabil Clin N Am. 2024. PMID: 38514230 Review.

10

The Community Paramedicine at Clinic Program: Improving Participant Health while Preserving Healthcare System Resources.

AlShenaiber L, Mahal G, Angeles R, Marzanek-Lefebvre F, Pirrie M, Keenan A, Agarwal G. AlShenaiber L, et al. Among authors: keenan a. Healthc Q. 2024 Jan;26(4):41-47. doi: 10.12927/hcq.2024.27254. Healthc Q. 2024. PMID: 38482648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters